Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

A new paravian dinosaur from the Late Jurassic of North America supports a late acquisition of avian flight.

Hartman S, Mortimer M, Wahl WR, Lomax DR, Lippincott J, Lovelace DM.

PeerJ. 2019 Jul 10;7:e7247. doi: 10.7717/peerj.7247. eCollection 2019.

2.

Autonomic responses to blast overpressure can be elicited by exclusively exposing the ear in rats.

Sandlin DS, Yu Y, Huang J, Zhang C, Arteaga AA, Lippincott JK, Peeden EOH, Guyton RR, Chen L, Beneke LLS, Allison JC, Zhu H, Zhou W.

J Otol. 2018 Jun;13(2):44-53. doi: 10.1016/j.joto.2018.01.001. Epub 2018 Mar 9.

3.

Firm, protuberant plaque on a 7-year-old's arm.

Lippincott J, Patel N, Jacks SK.

Pediatr Dermatol. 2018 May;35(3):403-405. doi: 10.1111/pde.13436. No abstract available.

PMID:
29749123
4.

A test of the Energetics-Hormone Vocalization model in the green treefrog.

Leary CJ, Lippincott J, Harris S, Hawkins DL.

Gen Comp Endocrinol. 2015 Mar 1;213:32-9. doi: 10.1016/j.ygcen.2014.12.017. Epub 2015 Jan 6.

PMID:
25575655
5.

Antitumor activity of an anti-CD98 antibody.

Hayes GM, Chinn L, Cantor JM, Cairns B, Levashova Z, Tran H, Velilla T, Duey D, Lippincott J, Zachwieja J, Ginsberg MH, H van der Horst E.

Int J Cancer. 2015 Aug 1;137(3):710-20. doi: 10.1002/ijc.29415. Epub 2015 Jan 14.

6.

Monoclonal antibody binding-site diversity assessment with a cell-based clustering assay.

Liao-Chan S, Zachwieja J, Gomez S, Duey D, Lippincott J, Theunissen JW.

J Immunol Methods. 2014 Mar;405:1-14. doi: 10.1016/j.jim.2013.12.007. Epub 2013 Dec 29.

PMID:
24380699
7.

Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells.

Qiu M, Peng Q, Jiang I, Carroll C, Han G, Rymer I, Lippincott J, Zachwieja J, Gajiwala K, Kraynov E, Thibault S, Stone D, Gao Y, Sofia S, Gallo J, Li G, Yang J, Li K, Wei P.

Cancer Lett. 2013 Jan 28;328(2):261-70. doi: 10.1016/j.canlet.2012.09.023. Epub 2012 Oct 3.

PMID:
23041621
8.

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies.

Hu-Lowe DD, Chen E, Zhang L, Watson KD, Mancuso P, Lappin P, Wickman G, Chen JH, Wang J, Jiang X, Amundson K, Simon R, Erbersdobler A, Bergqvist S, Feng Z, Swanson TA, Simmons BH, Lippincott J, Casperson GF, Levin WJ, Stampino CG, Shalinsky DR, Ferrara KW, Fiedler W, Bertolini F.

Cancer Res. 2011 Feb 15;71(4):1362-73. doi: 10.1158/0008-5472.CAN-10-1451. Epub 2011 Jan 6.

9.

Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model.

Grant S, Tran P, Zhang Q, Zou A, Dinh D, Jensen J, Zhou S, Kang X, Zachwieja J, Lippincott J, Liu K, Johnson SL, Scales S, Yin C, Nukui S, Stoner C, Prasanna G, Lafontaine J, Wells P, Li H.

Eur J Pharmacol. 2010 Feb 10;627(1-3):16-25. doi: 10.1016/j.ejphar.2009.10.029. Epub 2009 Oct 20.

PMID:
19850035
10.

Bni5p, a septin-interacting protein, is required for normal septin function and cytokinesis in Saccharomyces cerevisiae.

Lee PR, Song S, Ro HS, Park CJ, Lippincott J, Li R, Pringle JR, De Virgilio C, Longtine MS, Lee KS.

Mol Cell Biol. 2002 Oct;22(19):6906-20.

11.

Comparison: attitudes toward homosexuality of international and American college students.

Lippincott JA, Wlazelek B, Schumacher LJ.

Psychol Rep. 2000 Dec;87(3 Pt 2):1053-6.

PMID:
11272742
12.

The Tem1 small GTPase controls actomyosin and septin dynamics during cytokinesis.

Lippincott J, Shannon KB, Shou W, Deshaies RJ, Li R.

J Cell Sci. 2001 Apr;114(Pt 7):1379-86.

13.

An enduring partnership. AJN and Lippincott enter: another century together.

Lippincott J.

Am J Nurs. 2000 Oct;100(10):11. No abstract available.

PMID:
11059312
14.

Nuclear envelope fission is linked to cytokinesis in budding yeast.

Lippincott J, Li R.

Exp Cell Res. 2000 Nov 1;260(2):277-83.

PMID:
11035922
15.

Application of native-state electrospray mass spectrometry to identify zinc-binding sites on engineered hemoglobin.

Lippincott J, Fattor TJ, Lemon DD, Apostol I.

Anal Biochem. 2000 Sep 10;284(2):247-55.

PMID:
10964407
16.

Involvement of PCH family proteins in cytokinesis and actin distribution.

Lippincott J, Li R.

Microsc Res Tech. 2000 Apr 15;49(2):168-72. Review.

PMID:
10816256
17.
18.

Characterization of S6K2, a novel kinase homologous to S6K1.

Lee-Fruman KK, Kuo CJ, Lippincott J, Terada N, Blenis J.

Oncogene. 1999 Sep 9;18(36):5108-14.

19.
20.

Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications.

Kerwin BA, Akers MJ, Apostol I, Moore-Einsel C, Etter JE, Hess E, Lippincott J, Levine J, Mathews AJ, Revilla-Sharp P, Schubert R, Looker DL.

J Pharm Sci. 1999 Jan;88(1):79-88.

PMID:
9874706
22.

Identification of a nickel(II) binding site on hemoglobin which confers susceptibility to oxidative deamination and intramolecular cross-linking.

Levine J, Weickert M, Pagratis M, Etter J, Mathews A, Fattor T, Lippincott J, Apostol I.

J Biol Chem. 1998 May 22;273(21):13037-46.

24.

Incorporation of norvaline at leucine positions in recombinant human hemoglobin expressed in Escherichia coli.

Apostol I, Levine J, Lippincott J, Leach J, Hess E, Glascock CB, Weickert MJ, Blackmore R.

J Biol Chem. 1997 Nov 14;272(46):28980-8.

25.

Mapping of recombinant hemoglobin using immobilized trypsin cartridges.

Lippincott J, Hess E, Apostol I.

Anal Biochem. 1997 Oct 15;252(2):314-25.

PMID:
9344419
26.
27.

Recombinant protein sequences can trigger methylation of N-terminal amino acids in Escherichia coli.

Apostol I, Aitken J, Levine J, Lippincott J, Davidson JS, Abbott-Brown D.

Protein Sci. 1995 Dec;4(12):2616-8.

28.

Propensity for seeking counseling services: a comparison of Asian and American undergraduates.

Lippincott JA, Mierzwa JA.

J Am Coll Health. 1995 Mar;43(5):201-4.

PMID:
7499634
29.

How an academic health center and a community health center found common ground.

Redington TJ, Lippincott J, Lindsay D, Wones R.

Acad Med. 1995 Jan;70(1):21-6.

PMID:
7826437
30.
31.

The hard choices that we must make.

Harrison DC, Lippincott JR.

Consultant. 1988 Mar;28(3):82-3, 87-8, 91.

PMID:
10318054
32.

Cell walls of crown-gall tumors and embryonic plant tissues lack agrobacterium adherence sites.

Lippincott JA, Lippincott BB.

Science. 1978 Mar 10;199(4333):1075-8.

PMID:
17844419
33.

Plasmid content and tumor initiation complementation by Agrobacterium tumefaciens IIBNV6.

Lippincott BB, Margot JB, Lippincott JA.

J Bacteriol. 1977 Dec;132(3):824-31.

34.

Tumor induction by agrobacterium involves attachment of the bacterium to a site on the host plant cell wall.

Lippincott BB, Whatley MH, Lippincott JA.

Plant Physiol. 1977 Mar;59(3):388-90.

35.

Role of Agrobacterium cell envelope lipopolysaccharide in infection site attachment.

Whatley MH, Bodwin JS, Lippincott BB, Lippincott JA.

Infect Immun. 1976 Apr;13(4):1080-3.

36.

Induction of responsiveness to octopine and lysopine in crown-gall tumors.

Lippincott BB, Lippincott JA.

Plant Physiol. 1975 Aug;56(2):213-5.

37.

The genus Agrobacterium and plant tumorigenesis.

Lippincott JA, Lippincott BB.

Annu Rev Microbiol. 1975;29:377-405. No abstract available.

PMID:
1180518
38.

Utilization of octopine and nopaline by Agrobacterium.

Lippincott JA, Beiderbeck R, Lippincott BB.

J Bacteriol. 1973 Oct;116(1):378-83.

39.

On the question of crown-gall tumor initiation by DNA of bacteriophage PS8.

Beiderbeck R, Heberlein GT, Lippincott JA.

J Virol. 1973 Feb;11(2):345-50.

40.

Promotion of crown-gall tumor growth by lysopine, octopine, nopaline, and carnosine.

Lippincott JA, Lippincott BB, Chang CC.

Plant Physiol. 1972 Feb;49(2):131-7.

41.
42.

Bioassay and attributes of a growth factor associated with crown gall tumors.

Lippincott BB, Lippincott JA.

Plant Physiol. 1970 Nov;46(5):708-14.

43.
44.

Lysopine and Octopine Promote Crown-Gall Tumor Growth in vivo.

Lippincott JA, Lippincott BB.

Science. 1970 Oct 9;170(3954):176-7.

PMID:
17833501
45.

Growth requirements and infectivity of auxotrophic adenine-dependent mutants of Agrobacterium tumefaciens.

Schmidt RM, Lippincott BB, Lippincott JA.

Phytopathology. 1969 Oct;59(10):1451-4. No abstract available.

PMID:
5374246
46.

Tumor growth complementation among strains of Agrobacterium.

Lippincott JA, Lippincott BB.

J Bacteriol. 1969 Aug;99(2):496-502.

47.
48.

Enhancement of Agrobacterium tumefaciens infectivity by mitomycin C.

Heberlein GT, Lippincott JA.

J Bacteriol. 1967 Nov;94(5):1470-4.

49.

Ultraviolet-induced changes in the infectivity of Agrobacterium tumefaciens.

Heberlein GT, Lippincott JA.

J Bacteriol. 1967 Apr;93(4):1246-53.

50.

Time required for tumour initiation by Agrobacterium tumefaciens on pinto bean leaves.

Lippincott JA, Lippincott BB.

Nature. 1967 Feb 11;213(5076):596-8. No abstract available.

PMID:
6032253

Supplemental Content

Loading ...
Support Center